HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Raymond E Meyn Selected Research

Raymond E Meyn Research Topics

Disease

29Neoplasms (Cancer)
01/2022 - 03/2002
9Squamous Cell Carcinoma of Head and Neck
01/2021 - 01/2012
6Prostatic Neoplasms (Prostate Cancer)
07/2014 - 03/2002
6Melanoma (Melanoma, Malignant)
08/2006 - 06/2004
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 11/2003
3Head and Neck Neoplasms (Head and Neck Cancer)
01/2021 - 02/2015
3Lung Neoplasms (Lung Cancer)
08/2014 - 07/2002
2Neoplasm Metastasis (Metastasis)
08/2014 - 02/2006
2Breast Neoplasms (Breast Cancer)
07/2014 - 12/2007
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2008 - 04/2004
1Squamous Cell Neoplasms (Squamous Cell Cancer)
01/2018
1Hematologic Neoplasms (Hematological Malignancy)
03/2017
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2017
1Rectal Neoplasms (Rectal Cancer)
04/2016
1Hypoxia (Hypoxemia)
12/2015
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2009
1Disease Progression
09/2009
1Ataxia Telangiectasia (Louis Bar Syndrome)
11/2003
1B-Cell Lymphoma (Lymphoma, B Cell)
08/2003

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
01/2018 - 07/2005
3Biomarkers (Surrogate Marker)IBA
03/2017 - 12/2015
3CytokinesIBA
12/2007 - 08/2003
3Histone Deacetylase InhibitorsIBA
11/2006 - 07/2005
3interleukin-24 (ST16)IBA
02/2006 - 08/2003
2DNA (Deoxyribonucleic Acid)IBA
01/2022 - 02/2004
2Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2021 - 07/2014
2niraparibIBA
01/2021 - 07/2014
2Cisplatin (Platino)FDA LinkGeneric
03/2017 - 02/2015
2Lactic Acid (Lactate)FDA LinkGeneric
03/2017 - 12/2015
2Messenger RNA (mRNA)IBA
09/2016 - 07/2005
2Phosphotransferases (Kinase)IBA
02/2015 - 09/2011
2adavosertibIBA
02/2015 - 09/2011
2ErbB Receptors (EGF Receptor)IBA
01/2015 - 02/2008
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2007 - 06/2004
2trichostatin A (A 300)IBA
11/2006 - 07/2005
2Radiation-Sensitizing AgentsIBA
07/2005 - 08/2004
2DNA-Activated Protein KinaseIBA
07/2005 - 11/2003
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
08/2004 - 08/2003
2NF-kappa B (NF-kB)IBA
08/2004 - 08/2003
1UbiquitinIBA
01/2022
1Small Interfering RNA (siRNA)IBA
01/2021
1Deubiquitinating EnzymesIBA
01/2018
1Doxorubicin (Adriamycin)FDA LinkGeneric
03/2017
1PlatinumIBA
03/2017
1Carboplatin (JM8)FDA LinkGeneric
03/2017
1MK-8776IBA
11/2016
11,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
11/2016
1Checkpoint Kinase 1IBA
11/2016
1Nelfinavir (Viracept)FDA Link
04/2016
1HIV Protease InhibitorsIBA
04/2016
1Free Radical ScavengersIBA
12/2015
1Cetuximab (Erbitux)FDA Link
01/2015
1cixutumumabIBA
01/2015
1Somatomedin Receptors (Somatomedin Receptor)IBA
01/2015
1MicroRNAs (MicroRNA)IBA
08/2014
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
07/2014
1Metformin (Glucophage)FDA LinkGeneric
01/2012
1ABT-737IBA
12/2009
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2009
1Gefitinib (Iressa)FDA Link
02/2008
1LuciferasesIBA
12/2007
1Becaplermin (PDGF-BB)FDA Link
12/2007
1Chemokine ReceptorsIBA
12/2007
1Firefly LuciferasesIBA
12/2007
1Transforming Growth Factor beta1 (TGF beta 1)IBA
12/2007
1Renilla LuciferasesIBA
12/2007
1Inhibitor of Apoptosis ProteinsIBA
11/2006
1SurvivinIBA
11/2006
1Cyclin-Dependent Kinases (cdk Proteins)IBA
11/2006
1Mitogen-Activated Protein KinasesIBA
11/2006
16- ((3- chloro)anilino)- 2- (isopropyl- 2- hydroxyethylamino)- 9- isopropylpurineIBA
11/2006
12- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA
11/2006
1VorinostatFDA Link
08/2006
1Histone Deacetylases (Histone Deacetylase)IBA
08/2006
1ChromatinIBA
08/2006
1AntigensIBA
02/2006
1Granzymes (Granzyme)IBA
02/2006
1Butyric Acid (Butanoic Acid)IBA
07/2005
1Histones (Histone)IBA
07/2005
1tributyrinIBA
07/2005
1benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA
08/2004
12- (2- chloro- 4- iodophenylamino)- N- cyclopropylmethoxy- 3,4- difluorobenzamideIBA
08/2004
1bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA
04/2004
1Complementary DNA (cDNA)IBA
03/2004
1advexinIBA
11/2003
1Cadherins (E-Cadherin)IBA
08/2003
1beta CateninIBA
08/2003
1harringtoninIBA
06/2003
1PuromycinIBA
06/2003
1EmetineIBA
06/2003
1Cycloheximide (Cicloheximide)IBA
06/2003
1AnisomycinIBA
06/2003
1JNK Mitogen-Activated Protein KinasesIBA
06/2003
1LigandsIBA
06/2003
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2003
1Therapeutic UsesIBA
07/2002

Therapy/Procedure

17Radiotherapy
01/2022 - 04/2004
6Therapeutics
01/2022 - 06/2004
4Drug Therapy (Chemotherapy)
03/2017 - 02/2006
1Aftercare (After-Treatment)
09/2016